These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24273177)

  • 1. The complement C3a receptor is critical in defense against Chlamydia psittaci in mouse lung infection and required for antibody and optimal T cell response.
    Dutow P; Fehlhaber B; Bode J; Laudeley R; Rheinheimer C; Glage S; Wetsel RA; Pabst O; Klos A
    J Infect Dis; 2014 Apr; 209(8):1269-78. PubMed ID: 24273177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement and
    Kohn M; Lanfermann C; Laudeley R; Glage S; Rheinheimer C; Klos A
    Front Immunol; 2021; 12():626627. PubMed ID: 33746963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement and
    Kohn M; Lanfermann C; Laudeley R; Glage S; Rheinheimer C; Klos A
    Front Immunol; 2021; 12():580594. PubMed ID: 33767691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci.
    Bode J; Dutow P; Sommer K; Janik K; Glage S; Tümmler B; Munder A; Laudeley R; Sachse KW; Klos A
    PLoS One; 2012; 7(11):e50327. PubMed ID: 23189195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of C3a receptor attenuates the development of diabetic nephropathy.
    Li XQ; Chang DY; Chen M; Zhao MH
    BMJ Open Diabetes Res Care; 2019; 7(1):e000817. PubMed ID: 31798904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12 administered during Chlamydia psittaci lung infection in mice confers immediate and long-term protection and reduces macrophage inflammatory protein-2 level and neutrophil infiltration in lung tissue.
    Huang J; Wang MD; Lenz S; Gao D; Kaltenboeck B
    J Immunol; 1999 Feb; 162(4):2217-26. PubMed ID: 9973497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The receptor for the complement C3a anaphylatoxin (C3aR) provides host protection against Listeria monocytogenes-induced apoptosis.
    Mueller-Ortiz SL; Morales JE; Wetsel RA
    J Immunol; 2014 Aug; 193(3):1278-89. PubMed ID: 24981453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated human T lymphocytes express a functional C3a receptor.
    Werfel T; Kirchhoff K; Wittmann M; Begemann G; Kapp A; Heidenreich F; Götze O; Zwirner J
    J Immunol; 2000 Dec; 165(11):6599-605. PubMed ID: 11086104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma.
    Rothfuchs AG; Kreuger MR; Wigzell H; Rottenberg ME
    J Immunol; 2004 Feb; 172(4):2407-15. PubMed ID: 14764711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of the complement C3a anaphylatoxin receptor causes enhanced killing of Pseudomonas aeruginosa in a mouse model of pneumonia.
    Mueller-Ortiz SL; Hollmann TJ; Haviland DL; Wetsel RA
    Am J Physiol Lung Cell Mol Physiol; 2006 Aug; 291(2):L157-65. PubMed ID: 16461429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with Chlamydia psittaci plasmid-encoded protein CPSIT_p7 induces partial protective immunity against chlamydia lung infection in mice.
    Tan Y; Li Y; Zhang Y; Yu J; Wen Y; Wang C; Xu M; Chen Q; Lu C; Wu Y
    Immunol Res; 2018 Aug; 66(4):471-479. PubMed ID: 30097797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant multi-epitope peptide vaccine based on MOMP and CPSIT_p6 protein protects against Chlamydia psittaci lung infection.
    Li Y; Zheng K; Tan Y; Wen Y; Wang C; Chen Q; Yu J; Xu M; Tan M; Wu Y
    Appl Microbiol Biotechnol; 2019 Jan; 103(2):941-952. PubMed ID: 30467705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy.
    Drouin SM; Corry DB; Hollman TJ; Kildsgaard J; Wetsel RA
    J Immunol; 2002 Nov; 169(10):5926-33. PubMed ID: 12421977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of pulmonary Th17 responses by C3a anaphylatoxin during allergic inflammation in mice.
    Lim H; Kim YU; Drouin SM; Mueller-Ortiz S; Yun K; Morschl E; Wetsel RA; Chung Y
    PLoS One; 2012; 7(12):e52666. PubMed ID: 23285141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MOMP and MIP DNA-loaded bacterial ghosts reduce the severity of lung lesions in mice after Chlamydia psittaci respiratory tract infection.
    Zhou P; Wu H; Chen S; Bai Q; Chen X; Chen L; Zeng X; Liu L; Chen L
    Immunobiology; 2019 Nov; 224(6):739-746. PubMed ID: 31561842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
    Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
    FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of both the C3a and C5a receptors fails to protect against experimental autoimmune encephalomyelitis.
    Ramos TN; Wohler JE; Barnum SR
    Neurosci Lett; 2009 Dec; 467(3):234-6. PubMed ID: 19850104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant protein CPSIT_0846 induces protective immunity against Chlamydia psittaci infection in BALB/c mice.
    Ran O; Liang M; Yu J; Yu M; Song Y; Yimou W
    Pathog Dis; 2017 Apr; 75(3):. PubMed ID: 28204474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
    Laumonnier Y; Karsten CM; Köhl G; Köhl J
    Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intragastric primary infection sensitizes to lung reinfection in a Chlamydia pneumoniae mouse model.
    Erkkilä L; Saario E; Laitinen K; Saikku P; Leinonen M
    Vaccine; 2008 May; 26(20):2503-9. PubMed ID: 18433949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.